Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Tokyo Big Sight

16 nov 2014 9:00 a.m. - 18 nov 2014 6:30 p.m.

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

11th Annual Meeting DIA Japan 2014

Session Chair(s)

Tomoko  Hirohashi, PHD

Tomoko Hirohashi, PHD

Director, Clinical Research Oncology

Pfizer Japan Inc., Japan

Speaker(s)

Tomoko  Hirohashi, PHD

Brain Storming How We Can Concudt Clinical Trials? A Company-Funded Company-Lead Trials is Not Only the Way to Run a Clinical Trial? - Introduction

Tomoko Hirohashi, PHD

Pfizer Japan Inc., Japan

Director, Clinical Research Oncology

Tomio  Nakamura

Clinical Development Strategy Including Company-Initiated Clinical Study

Tomio Nakamura

Eisai Co., Ltd., Japan

Senior Director, Japan/Asia Clinical Development Oncology Group

Koichi  Goto, MD, PHD

Drug development based on the collaboration between Academia and the companies- Proposal and requests from Academia-

Koichi Goto, MD, PHD

Daiichi Sankyo Company, Limited, Japan

Scientist, Medicinal Research Laboratories

Akihira  Mukaiyama, MSC

Experience of Collaboration with External Partners - The Case of Non-Domestic Company -

Akihira Mukaiyama, MSC

GlaxoSmithKline K.K., Japan

Manager, Medicines Development, Development & Medical Afffairs Division

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.